drugset / Trial / NCT01442363
A Safety and Efficacy Study of BLI-1300 Ointment in Symptomatic Perianal Crohn's Disease
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This randomized, placebo-controlled, parallel, multi-center, double-blind pilot study is designed to determine the effects of BLI-1300 ointment on perianal pain associated with active Perianal Crohn's Disease (PCD).
Timeline
- Start
- 2011-11
- Primary completion
- 2012-10
- Completion
- 2012-10
Outcome
Outcome not reported
Stopped (Enrollment): “Lack of recruitment, discontinuation of program”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BLI-1300 | Unknown | 10 % | Topical |
| Subject | BLI-1300 | Unknown | 20 % | Topical |